Why the study?
Do beta-adrenergic blocking drugs reduce mortality and nonfatal myocardial infarction in patients after myocardial infarction?
Population
Patients in the first 2 years after myocardial infarction
Comparison
Beta-adrenergic blocking drugs vs Placebo
Design
Editorial
Authors
Loading...
This editorial highlights the established evidence that beta-blockers significantly reduce mortality and nonfatal reinfarction in the first two years following a myocardial infarction.
Do beta-adrenergic blocking drugs reduce mortality and nonfatal myocardial infarction in patients after myocardial infarction?
This editorial highlights the established evidence that beta-blockers significantly reduce mortality and nonfatal reinfarction in the first two years following a myocardial infarction.
J. Thomas Bigger (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: